Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common side effects of Mounjaro (tirzepatide), affecting a meaningful proportion of people during the early weeks of treatment. It is not a sign the medicine has failed, nor that something has gone seriously wrong. Most cases are loose stools tied to how tirzepatide slows digestion, and they settle as the body adjusts. That said, these are prescription-only medicines: a GPhC-registered prescriber reviews your health picture before treatment begins, and side effects like this are part of that clinical conversation. The NHS medicines page for tirzepatide lists diarrhoea among the known common effects, which is the starting point for understanding what you're experiencing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of: "I've had loose stools since starting, should I stop?" The short answer is almost always no, not yet. The myth is that gut symptoms signal incompatibility. The fact is that tirzepatide's dual action on GIP and GLP-1 receptors slows how quickly food moves through the stomach. That change in transit time unsettles the bowel in many people, particularly in the first few weeks or after a dose step up. The discomfort is real; the meaning people assign to it (that the treatment is failing or harmful) usually isn't accurate.
It's also worth knowing that diarrhoea tends to be most noticeable at the 2.5mg starting dose and again at each increase. The mechanism behind Mounjaro's side-effect profile explains why these transition points matter. Gastric emptying changes are a feature, not a flaw, of how the medicine works. Tracking whether symptoms arrived with a dose change is genuinely useful information for your prescriber.
Fatty or very rich meals reliably make things worse. Smaller portions (something the medicine tends to encourage anyway) and staying well hydrated are the two practical adjustments that most people find helpful first.
For most people, loose stools after starting or increasing Mounjaro settle within one to two weeks. That's consistent with what the clinical trial programme reported and with what the NHS tirzepatide guidance notes. It doesn't feel quick when you're in it, but the pattern is predictable: the gut adjusts, and frequency normalises.
If symptoms persist well beyond two weeks at a stable dose, or keep returning with the same intensity rather than fading, that's worth raising with your prescriber rather than waiting through another week hoping they'll pass. You can explore the fuller picture of Mounjaro's side-effect profile to put diarrhoea alongside the other GI effects that commonly travel with it. Nausea, for instance, often appears alongside loose stools, and some of the same dietary adjustments help both. Our page on Mounjaro causing sickness goes into that parallel experience in more detail.
Diarrhoea that arrives suddenly, is severe, or is accompanied by signs of dehydration (dark urine, dizziness, a dry mouth, or significantly reduced urination) needs prompt attention. That's a different clinical picture from the mild looseness that follows a dose increase.
Not every bout of diarrhoea on Mounjaro is routine. The signs that should prompt you to contact a GP, prescriber, or 111 without waiting include: diarrhoea that is severe or bloody, any signs of dehydration (dizziness, confusion, very little urine output), vomiting alongside persistent diarrhoea that prevents you keeping fluids down, or symptoms that are getting worse rather than plateauing after a week or two.
Separately, the MHRA has highlighted that severe, persistent stomach pain (particularly pain that spreads to the back) alongside vomiting could indicate acute pancreatitis, a known but infrequent side effect of GLP-1 medicines. This is distinct from ordinary diarrhoea but worth knowing. If you experience that pattern, seek urgent care. You can report any suspected side effect using the MHRA's Yellow Card scheme, which helps build the national safety picture for all medicines including tirzepatide.
For ongoing concerns that don't reach the threshold of an emergency but feel unmanaged, our aftercare team is available seven days a week. Side effects like this are exactly the sort of thing that review is for.
There are a few things that consistently help people get through the adjustment phase. Eating smaller meals, avoiding high-fat and spicy foods around injection day, and keeping fluid intake up are the most reliably useful. Some people find that taking Mounjaro on a day when they can rest (rather than before a busy work morning) makes the first few weeks easier to manage.
It's also worth knowing that other GI effects sometimes accompany diarrhoea: constipation can follow a bout of loose stools as the gut recalibrates, and some people find the two alternate in the early weeks. The broader guide to diarrhoea on Mounjaro covers these patterns in full. Less commonly reported are effects like hair changes or mood shifts, if you're curious whether those have any connection, our pages on hair loss with Mounjaro and anxiety while on Mounjaro address those questions directly.
Mounjaro is a prescription-only medicine. If you're considering starting treatment, our prescribers discuss your full health picture (including how you're likely to tolerate the GI side effects and what to do if they're troublesome) as part of the free consultation. Speak to our prescribers to check your suitability.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.